Replying to @ResearchPulse1 @CloisterRes
Understood. I'm seeing the attached in my FS alerts and just wondering if the highlighted part is the only context or if FS +/- IQVIA (I have access to both) let's you figure out the granular numbers
1
1
140
Replying to @PersimmonTI @Nature
Generally deal activity has been picking up since Q4/Q1. Tough sell on valuation premiums now though vs that time period
16
Replying to @paras_biotech
Needham had a report on this too. Generally 1day premiums trending down over time, along with EV/Peak sales
$XBI
242
Interesting times: "US VC secondary transactions totaled $61.1 billion from June 2024 to June 2025, leapfrogging IPO exit value of $58.8 billion over the same period, according to PitchBook data."
60
Given the mRNA conversations recently, I thought this poll from @bradloncar in the depths of the pandemic was appropriate to resurface.
I'll note ofc that deciding whether something will "work" is different than whether it should be studied.
1
74
Replying to @AppleHelix
Nice story here from the team (podcast version also available). I didn't appreciate the financial acumen prior
youtu.be/iyVAoPejafY?si=hTEM…
1
4
370





















